Virtual Issue: Antibody-mediated rejection (ABMR)

Published on 02/17/10

Guest Editors: Drs. Philip F. Halloran and Michael Mengel

Read this Virtual Issue on Antibody-mediated rejection (ABMR)

Antibody-mediated rejection (ABMR) is increasingly recognized as one of the biggest challenges in organ transplantation. This virtual issue presents a sample of articles addressing ABMR issues selected from many other articles of interest in AJT on the basis of citation rates and download rates, reflecting impact on the transplantation community. With the exception of liver, ABMR phenotypes probably contribute to late loss of many organ transplants and islet transplants. ABMR can be subtle or explosive, and presents in two main variants: early onset in presensitized persons, often with positive crossmatches; and late insidious onset, usually with de novo anti HLA, particularly anti class II.

Virtual Issue compiled online 17 Feb 2010

Search the Site

Search


 

KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients

Read The AJT Report

American Transplant Congress 2010